SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zim Laboratories - Quaterly Results

09 Nov 2024 Evaluate
A fair growth of 5.23% in the revenue at Rs. 897.21 millions was reported in the September 2024 quarter as compared to Rs. 852.60 millions during year-ago period.Profit after Tax for the quarter ended September 2024 saw a decline of -70.86% from Rs. 41.77 millions to Rs. 12.17  millions.Operating Profit reported a sharp decline to 97.12 millions from 103.83 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 897.21 852.60 5.23 1717.25 1522.67 12.78 3654.73 3965.31 -7.83
Other Income 13.22 14.21 -6.97 23.02 20.53 12.13 46.91 64.31 -27.06
PBIDT 97.12 103.83 -6.46 185.70 155.55 19.38 447.94 576.21 -22.26
Interest 28.86 12.17 137.14 57.44 29.51 94.65 69.24 55.75 24.20
PBDT 68.26 91.66 -25.53 128.26 126.04 1.76 378.70 520.46 -27.24
Depreciation 49.73 37.17 33.79 98.89 73.77 34.05 148.29 161.28 -8.05
PBT 18.53 54.49 -65.99 29.37 52.27 -43.81 230.41 359.18 -35.85
TAX 6.36 12.72 -50.00 9.61 11.92 -19.38 62.84 109.09 -42.40
Deferred Tax 4.00 4.53 -11.70 5.15 3.73 38.07 54.55 46.30 17.82
PAT 12.17 41.77 -70.86 19.76 40.35 -51.03 167.57 250.09 -33.00
Equity 487.26 487.26 0.00 487.26 487.26 0.00 487.26 487.26 0.00
PBIDTM(%) 10.82 12.18 -11.11 10.81 10.22 5.86 12.26 14.53 -15.66

Zim Laboratories Share Price

76.00 -0.08 (-0.11%)
16-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1693.15
Dr. Reddys Lab 1221.25
Cipla 1230.75
Zydus Lifesciences 939.20
Lupin 2326.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×